[1]
“PROGNOSTIC IMPACT OF IMMUNOHISTOCHEMICAL P53 EXPRESSION IN BONE MARROW BIOPSY IN HIGHER RISK MDS: A PILOT STUDY”, Mediterr J Hematol Infect Dis, vol. 11, no. 1, p. e2019015, Feb. 2019, doi: 10.4084/mjhid.2019.015.